An interventional study of Posterior Component Separation with Transversus Abdominis Muscle Release and Mesh-only repair in Hernia, Ventral, Hernia Incisional and Hernia, Abdominal, sponsored by Mansoura University. Status unknown at 1 site in Egypt. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2020-08-17.
Sponsored by Mansoura University · Not applicable, Interventional, and Treatment
Among 13 studies in Hernia, Ventral with a site in Egypt — 4 open to participants now, 4 under way, none of them phase 3. Hernia, Ventral · Egypt.
Among the 13 studies in Hernia, Ventral with a site in Egypt, this one is the 6th largest by planned enrollment of the 11 interventional ones, is the only one that started in 2018, is one of 12 with no phase, and was the 5th registered.
230 studies on the registry are indexed under Hernia, Ventral; 45 are open to participants now.
This study's planned enrollment of 59 is below the median of 90 across 153 interventional studies indexed under Hernia, Ventral.
Browse Hernia, Ventral studies →4 of the 13 studies in Hernia, Ventral with a site in Egypt are open now, in 1 country. Each count lists the studies.
Of the 26 Hernia, Ventral studies recruiting now, 19 (73%) set no upper age limit and 4 (15%) stop at 75 or younger; 1 take children under 18; 6 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →13 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2018.
Median enrollment 59 across the 11 interventional studies, 420 across the 1 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
None of the 13 has an industry lead sponsor. The 7 most frequent:
Mansoura University is the lead sponsor of 1,119 studies on the registry; 183 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Mansoura University has 4 studies filed under Hernia, Ventral — fewer than ten, so there is no comparison to draw.
2 of the studies in Hernia, Ventral with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07720154Minia UniversityHernia Sac Flap Coverage of Mesh in Bony-Edged Ventral Hernia Repair | 2027-08-15 |
| NCT07725718Minia UniversityRisk Factors for Mesh Infection After Abdominal Wall Reconstruction | 2027-11-15 |
Among the 13 studies in Hernia, Ventral with a site in Egypt, from their registry updates:
This trial was designed as a prospective randomized, controlled, intervention, with two parallel groups, and a primary endpoint of recurrence during 12 months' follow-up after initial treatment, with the randomization, was performed by an online software a 1:1 allocation.
Eligibility Criteria
Exclusion
Interventions
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Procedure: Mesh-only repair
Procedure: Posterior Component Separation with Transversus Abdominis Muscle Release
The posterior component separation technique with transversus abdominis muscle release was done as prescribed in Novitsky et al in 2012.
Also known as: Transversus Abdominis Muscle Release
The prosthetic mesh only repair was done as described by Wantz in 1991.
Hernia recurrence
Reappearance of symptoms or swelling
Time frame: after 12 months
Morbidity
postoperative morbidity
Time frame: 30 days postoperative
Mortality
Postoperative mortality
Time frame: 30 days postoperative
Plan to share: Undecided
Started Aug 2018 (actual). Primary completion is estimated for Sep 2020, 25 months after the start.
Of 75 non-industry interventional studies with no phase under Hernia, Ventral, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 48. This study's planned 25 months is below that.
Counting every sponsor, half of 88 studies reached it within 37 months; a quarter within 19 and three quarters within 56.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.